Amplify Weight Loss Drug & Treatment ETF (THNR) at a glance

Amplify Weight Loss Drug & Treatment ETF (THNR) is a company. It trades at $24.42, with a P/E of 19.5. It pays a 1.7% dividend yield. Vestovix scores it 53/100 overall. Its strongest dimension is Value (60/100) and its weakest is Income (44/100).

Price
$24.42
Market cap
n/a
P/E ratio
19.5
Dividend yield
1.69%
Beta
n/a
52-week range
$21.70 to $27.28
Vestovix Score53/ 100How this works
Value
60
Growth
50
Income
44
Safety
60
Momentum
49